An editor has nominated this article for deletion. You are welcome to participate in the deletion discussion, which will decide whether or not to retain it. |
Jennifer Cook was the Chief Executive Officer at GRAIL (company) until June 2019 and was formerly the head of clinical operations at Roche.[1][2] She started in early-stage research at Genentech and held key positions including leading a U.S. commercial business unit and the Head of Pharma operations of Europe. She worked for 4 years at Prizm Pharmaceuticals. In 2016, she was recognized as Woman of the Year by the Healthcare Businesswoman's Association.[3]
Jennifer Cook | |
|---|---|
| Born | San Francisco, California |
| Nationality | American |
| Alma mater | Stanford University, Haas School of Business |
| Known for | CEO of Grail |
| Scientific career | |
| Fields | Medicine |
| Institutions | Genentech, GRAIL (company) |
She has a BA in human biology and a Masters in biology from Stanford University, and an MBA from the Haas School of Business at University of California, Berkeley.[4]
Cook was born and raised in San Francisco. Her father was an attorney, and her older sister, Alison Cook-Sather, is a professor at Bryn Mawr College.
References
edit- ^ "GRAIL Announces Appointment of Jennifer Cook as Chief Executive Officer". www.businesswire.com.
- ^ Keown, Alex (December 14, 2017). "GRAIL Poaches New CEO From Roche, Genentech". BioSpace. Retrieved 2 May 2019.
- ^ "2016 Jennifer Cook | HBA". www.hbanet.org.
- ^ Raven, Kathleen (15 April 2016). "HBA's Woman of the Year 2016". www.pharmexec.com. Retrieved 15 December 2017.
 | This article about a chief executive from the United States is a stub. You can help Wikipedia by expanding it. |